pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 13·1 min read
save

Biopharma launches nominations for 2025 pay report and highlights Parabilis record IPO

Jun 13, 2026·read at Endpoints ↗DealNeutral

Endpoints Weekly announced the start of nominations for its eighth annual Women in Biopharma report, aiming to feature 20 distinguished women across science, leadership, and entrepreneurship.

The call invites scientists, executives, founders and other enterprising women to share their experiences and contributions to the biopharma sector.

In the same briefing, the newsletter noted that Parabilis achieved a record-setting initial public offering, marking a significant milestone for the company and the industry.

The combined announcements underscore ongoing efforts to highlight diversity in biopharma while tracking notable financial events.

source

This writeup was produced by pharmadog from original reporting by Endpoints. The original article may no longer be reachable at its published URL.

Original headline: “Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more”

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 12h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 15h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 16h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 16h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 17h agoHealth tech investors are looking at bigger betsEndpoints